Racing Toward Efficient AI Workflows
-
By
-
Devinder Chauhan, MD, FRCOphth, FRANZCO
-
May 1, 2026
-
2 min
By
Devinder Chauhan, MD, FRCOphth, FRANZCO
May 1, 2026
Authors describe both potential retinal benefits and possible rare optic nerve risks, while emphasizing that long-term ocular safety data remain limited as use expands.
by Kerri Miller
March 24, 2026
Although the trial missed its primary endpoint, exploratory analyses suggested slower lesion growth and better functional outcomes with gildeuretinol.
July 20, 2026
Meta-analysis found statistically significant improvements, with clearest benefits in early-stage disease
May 5, 2026